These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1825814)

  • 1. Vaginosonographic measurement of endometrial thickness in the evaluation of amenorrhea.
    Morcos RN; Leonard MD; Smith M; Bourguet C; Makii M; Khawli O
    Fertil Steril; 1991 Mar; 55(3):543-6. PubMed ID: 1825814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between sonographic endometrial thickness and progestin-induced withdrawal bleeding.
    Nakamura S; Douchi T; Oki T; Ijuin H; Yamamoto S; Nagata Y
    Obstet Gynecol; 1996 May; 87(5 Pt 1):722-5. PubMed ID: 8677074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with withdrawal bleeding after administration of oral dydrogesterone or medroxyprogesterone acetate in women with secondary amenorrhea.
    Battino S; Ben-Ami M; Geslevich Y; Weiner E; Shalev E
    Gynecol Obstet Invest; 1996; 42(2):113-6. PubMed ID: 8878716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM; Witjaksono J; Affandi B; Rogers PA
    Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between progesterone receptor level in endometrium and bleeding pattern in depot medroxyprogesterone acetate users.
    Chotnopparatpattara P; Taneepanichskul S; Treratanachat S; Charuruks N
    J Med Assoc Thai; 2003 Feb; 86(2):172-7. PubMed ID: 12678156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial histopathology, ovarian changes and bleeding patterns among users of long-acting progestin-only contraceptives in Egypt.
    Laban M; Abd Alhamid M; Ibrahim EA; Elyan A; Ibrahim A
    Eur J Contracept Reprod Health Care; 2012 Dec; 17(6):451-7. PubMed ID: 23113539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
    Odmark IS; Jonsson B; Bäckström T
    Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonic assessment of the endometrium as a predictor of oestrogen status in amenorrhoeic patients.
    Shulman A; Shulman N; Weissenglass L; Bahary C
    Hum Reprod; 1989 Aug; 4(6):616-9. PubMed ID: 2778044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of progesterone challenge test and endometrium thickness evaluated by transvaginal ultrasonography in the preventive management of postmenopausal women.
    Pansini F; De Paoli D; Serra MM; Campobasso C; Levato F; Giulini D
    Gynecol Obstet Invest; 1992; 34(4):237-9. PubMed ID: 1487184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A "no-bleeding" substitute hormone treatment with an oral microdose progesterone. A prospective multicenter study].
    Gillet JY; Faguer B; André G; Magnin G; de Lignières B; Philippe E
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(4):407-12. PubMed ID: 8051369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy.
    Turner SJ; Mizock GB; Feldman GL
    Am J Obstet Gynecol; 1966 May; 95(2):222-7. PubMed ID: 5935707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
    Sereepapong W; Chotnopparatpattara P; Taneepanichskul S; Markham R; Russell P; Fraser IS
    Hum Reprod; 2004 Mar; 19(3):547-52. PubMed ID: 14998949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial.
    AinMelk Y
    Fertil Steril; 1996 Dec; 66(6):962-8. PubMed ID: 8941062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonographic endometrial thickness: a useful test to predict atrophy in patients with postmenopausal bleeding. An Italian multicenter study.
    Ferrazzi E; Torri V; Trio D; Zannoni E; Filiberto S; Dordoni D
    Ultrasound Obstet Gynecol; 1996 May; 7(5):315-21. PubMed ID: 8774095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive and endometrial effects of medroxyprogesterone acetate.
    Lee RA
    Am J Obstet Gynecol; 1969 May; 104(1):130-3. PubMed ID: 5777697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial thickness after menopause: effect of hormone replacement.
    Lin MC; Gosink BB; Wolf SI; Feldesman MR; Stuenkel CA; Braly PS; Pretorius DH
    Radiology; 1991 Aug; 180(2):427-32. PubMed ID: 1829843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic hormone replacement therapy using quarterly progestin.
    Ettinger B; Selby J; Citron JT; Vangessel A; Ettinger VM; Hendrickson MR
    Obstet Gynecol; 1994 May; 83(5 Pt 1):693-700. PubMed ID: 8164927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.